随着全球制药行业竞争愈发激烈上演,药品专利到期早已成为各大药企不得不面对的关键挑战之一。今年则尤为关键,自2025年起,多款年销数十亿的畅销药物即将接连失去专利保护或市场独占权,在接下来的5年内,市场将迎来新一轮的到期潮,在或将重塑的竞争格局下,对各大药企提出应对挑战。悄然逼近的专利悬崖,背后是分秒必争的市场攻防,跃跃欲试的多种替代产品,无疑将对原研药企营收和市场份额造成强烈冲击。对于近在咫尺的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.